Larson Financial Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$127K Buy
2,022
+528
+35% +$36.8K ﹤0.01% 885
2025
Q4
$99.2K Sell
1,494
-82
-5% -$5.3K ﹤0.01% 934
2025
Q3
$106K Sell
1,576
-308
-16% -$24.4K ﹤0.01% 878
2025
Q2
$164K Sell
1,884
-443
-19% -$34.7K 0.01% 703
2025
Q1
$159K Buy
2,327
+1,852
+390% +$151K 0.01% 673
2024
Q4
$36.9K Buy
475
+137
+41% +$10.1K ﹤0.01% 994
2024
Q3
$22.7K Buy
338
+5
+2% +$411 ﹤0.01% 1153
2024
Q2
$37.8K Buy
333
+24
+8% +$3.03K ﹤0.01% 878
2024
Q1
$42.9K Hold
309
﹤0.01% 727
2023
Q4
$38.3K Buy
309
+1
+0.3% +$102 ﹤0.01% 704
2023
Q3
$28.7K Hold
308
﹤0.01% 735
2023
Q2
$39.6K Hold
308
﹤0.01% 603
2023
Q1
$35.8K Buy
308
+8
+3% +$896 ﹤0.01% 615
2022
Q4
$34K Hold
300
﹤0.01% 593
2022
Q3
$24K Buy
+300
New +$25.4K ﹤0.01% 589
2022
Q1
Sell
-12
Closed -$2K 1072
2021
Q4
$2K Buy
+12
New +$1.72K ﹤0.01% 940

Other funds holding DXCM